2019

The organization was rebranded as Caligor Coghlan Pharma Services.

2017

Caligor Opco acquired The Coghlan Group. Through this acquisition, Caligor Opco expanded our service offerings to include secondary packaging and labeling.

2016

Diversis Capital, a Los Angeles-based private equity group, acquired Caligor Rx and renamed the company Caligor Opco. This significant business change and the associated investment afforded Caligor Opco the opportunity to expand and enhance services for our...

2015

Caligor Rx added pre-approval access / expanded access program design and support to its menu of services after identifying a gap in the market for a high-touch, full-service model.

2001

Caligor Rx evolved to offer comparator and ancillary product procurement to sponsors for global clinical trial use.